Hunt for Russ­ian oli­garch’s bil­lions leads to biotech ac­tivist in­vestor Alex Den­ner’s fund — re­port

The glob­al drag­net be­ing thrown out to cap­ture bil­lions of dol­lars in Russ­ian oli­garch mon­ey has spot­light­ed the role of an ac­tivist in­vestor who’s spurred some of the most promi­nent re­or­ga­ni­za­tions in biotech.

Fol­low­ing a sto­ry in the Wall Street Jour­nal, the New York Times to­day flagged Alex Den­ner’s Saris­sa Cap­i­tal Man­age­ment as one of a long list of funds that have worked with a low-pro­file firm called Con­cord Man­age­ment. Ac­cord­ing to both news­pa­pers, Con­cord has steered mas­sive in­vest­ments from Russ­ian oli­garch Ro­man Abramovich — worth an es­ti­mat­ed $13 bil­lion — to a va­ri­ety of funds, in­clud­ing Saris­sa, while keep­ing the oli­garch’s name out of the trans­ac­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER